Skip to content

Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes

Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02416011
Enrollment
2896
Registered
2015-04-14
Start date
2015-03-31
Completion date
2019-06-30
Last updated
2022-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

e-cigarette, nicotine dependence

Brief summary

The purpose of this study is to develop and test a series of booklets designed to assist smokers of tobacco cigarettes who are also using e-cigarettes (dual users) in quitting smoking and remaining smoke-free.

Detailed description

The first two aims of the present proposal are to adapt a validated self-help, smoking-cessation intervention to meet the needs of current dual users, and to test this new intervention in a randomized controlled trial (RCT). A third primary aim is to calculate the cost-effectiveness of the intervention. A secondary aim is to gather longitudinal data regarding the patterns of tobacco and e-cigarette use and the course of cessation of either product among dual users. Specific Aim 1. To create a minimal smoking-cessation intervention for current dual users of tobacco cigarettes and e-cigarettes (Study I). The intervention will comprise a series of booklets and pamphlets modeled after the Forever Free booklets found to be successful at producing long-term abstinence among the general population of smokers, but adapted to the special needs, circumstances, and risk factors of dual users. Validated methodologies used for adapting the intervention mirror those used in our prior smoking cessation studies, and reflect systematic approaches across two-phases informed by individual interviews and learner verification methodologies. The intervention will provide assistance for smoking cessation, and also encourage users to taper and eventually terminate their e-cigarette use as per traditional nicotine replacement therapy (NRT). The end product of Study I will be a series of booklets tentatively titled, If You Vape: Guide to Quitting Smoking, available both in printed and electronic formats. Specific Aim 2. To evaluate the efficacy of the intervention via a randomized, controlled clinical trial of current dual users (Study II). We will compare the intervention developed under Specific Aim 1 with both an assessment-only condition and a generic self-help condition comprising existing smoking cessation booklets. We hypothesize that recipients of our targeted If You Vape booklets will show higher rates of tobacco abstinence at 6, 12, 18, and 24 months after enrollment, as compared to both comparison conditions. A secondary hypothesis is that the new intervention will produce higher rates of abstinence from e-cigarettes themselves. To identify mechanism of change, we will also test several a priori moderator and mediator variables, including gender, socio-economic status, motivation to quit, nicotine dependence, e-cigarette expectancies, and magnitude of e-cigarette use (frequency, dosage). Specific Aim 3. To calculate and compare the cost-effectiveness of the interventions. Cost- effectiveness data are vital for evaluating the real-world feasibility of an intervention. Small improvements in treatment efficacy may not be justified if they require substantially greater cost. We will compare the interventions not only on outcome efficacy, but on cost-effectiveness with respect to cost per incremental cessation and expected life-years saved.

Interventions

BEHAVIORALGENERIC

The initial Stop Smoking for Good brochure, 10 Stop Smoking for Good booklets and 9 supportive My Story pamphlets delivered over 18 months, as used in our previous cessation study.

BEHAVIORALeTARGET

The product of Study I is expected to include the initial If You Vape brochure, a series of 10 If You Vape: Guide to Quitting Smoking booklets, distributed over 18 months, and 9 supportive My Story pamphlets, delivered in the months between booklets.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
National Institutes of Health (NIH)
CollaboratorNIH
H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Study I - First Phase - No Longer Recruiting * Greater than 1 year history of daily smoking * 1 month or more of e-cigarette use * Able to speak and read English * (1) current dual users (of tobacco cigarettes and e-cigarettes) without interest in quitting smoking; (2) current dual users who have attempted, but not quit smoking; (3) current e-cigarette users who have successfully quit smoking; and (4) former dual users who have quit both products. * Study I - Second Phase - No Longer Recruiting * Current dual users (of tobacco cigarettes and e-cigarettes) * Smoking at least one cigarette per day over the past year * Using e-cigarettes at least once per week over the past month * Not currently enrolled in a face-to-face smoking cessation program * Able to speak and read English * Study II - No Longer Recruiting * Current dual users (of tobacco cigarettes and e-cigarettes) * Smoking at least one cigarette per week over the past year * Using e-cigarettes at least once per week over the past month * Not currently enrolled in a face-to-face smoking cessation program * Able to speak and read English

Design outcomes

Primary

MeasureTime frameDescription
Rate of Smoking Abstinence18 months & 24 months post study enrollmentPercentage rate of smoking abstinence for participants who received If You Vape booklets, compared to: A) participants in an assessment-only condition; B) participants in a generic self-help condition comprising existing smoking cessation booklets.

Secondary

MeasureTime frameDescription
Changes in the Use of Tobacco Products18 and 24 months post study enrollmentAs a surveillance study, investigators will track changes in the use of both tobacco cigarettes and e-cigarettes over time for ASSESS group only

Other

MeasureTime frameDescription
Study 2: Cost Effectiveness18 months and 24 months after study recruitmentCost per incremental cessation will be measured using USD spent on the self help materials provided to the participants in the Generic and eTarget groups at 18 months and 24 months. \*\*\*Total cost was calculated for the intervention and not calculated as per participant cost

Countries

United States

Participant flow

Participants by arm

ArmCount
Assessment Only (ASSESS)
Participants in this condition will not receive any intervention materials. They will participate solely in the repeated assessments. Including this comparison condition controls for the effect of repeated assessments and allows for the most meaningful evaluation of the efficacy effect size as well as the cost-effectiveness of the eTARGET intervention. This condition will also be the primary source of data for the secondary surveillance aim regarding naturalistic changes in smoking and e-cigarette use over time.
575
Generic Self-Help (GENERIC)
This will allow us to evaluate our novel self-help intervention for e-cigarette users (our If you Vape booklets) against a matched non-targeted intervention that has demonstrated efficacy for cigarette smokers in general. Such a comparison controls for the possibility that e-cigarette users are sufficiently primed to quit smoking and that even a generic, non-targeted intervention would be effective. This possibility will be directly tested by comparing this condition against both the ASSESS and eTARGET conditions in terms of clinical outcomes and cost-effectiveness. GENERIC: The initial Stop Smoking for Good brochure, 10 Stop Smoking for Good booklets and 9 supportive My Story pamphlets delivered over 18 months, as used in our previous cessation study.
1,154
Targeted Self-Help (eTARGET)
Participants in this condition will receive the intervention created as the product of Study I. eTARGET: The product of Study I is expected to include the initial If You Vape brochure, a series of 10 If You Vape: Guide to Quitting Smoking booklets, distributed over 18 months, and 9 supportive My Story pamphlets, delivered in the months between booklets.
1,167
Total2,896

Baseline characteristics

CharacteristicAssessment Only (ASSESS)Generic Self-Help (GENERIC)Targeted Self-Help (eTARGET)Total
Age, Categorical
<=18 years
30 Participants69 Participants76 Participants175 Participants
Age, Categorical
>=65 years
6 Participants12 Participants6 Participants24 Participants
Age, Categorical
Between 18 and 65 years
539 Participants1073 Participants1085 Participants2697 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
65 Participants87 Participants89 Participants241 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
510 Participants1067 Participants1078 Participants2655 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
15 Participants27 Participants11 Participants53 Participants
Race (NIH/OMB)
Asian
5 Participants9 Participants9 Participants23 Participants
Race (NIH/OMB)
Black or African American
10 Participants35 Participants41 Participants86 Participants
Race (NIH/OMB)
More than one race
27 Participants57 Participants64 Participants148 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
3 Participants8 Participants7 Participants18 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants6 Participants10 Participants18 Participants
Race (NIH/OMB)
White
513 Participants1012 Participants1025 Participants2550 Participants
Region of Enrollment
United States
575 participants1154 participants1167 participants2896 participants
Sex: Female, Male
Female
207 Participants435 Participants424 Participants1066 Participants
Sex: Female, Male
Male
368 Participants719 Participants743 Participants1830 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 0
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Rate of Smoking Abstinence

Percentage rate of smoking abstinence for participants who received If You Vape booklets, compared to: A) participants in an assessment-only condition; B) participants in a generic self-help condition comprising existing smoking cessation booklets.

Time frame: 18 months & 24 months post study enrollment

ArmMeasureValue (NUMBER)
ASSESS at 18 MonthsRate of Smoking Abstinence33 percentage of participants
ASSESS at 24 MonthsRate of Smoking Abstinence40 percentage of participants
GENERIC at 18 MonthsRate of Smoking Abstinence37 percentage of participants
GENERIC at 24 MonthsRate of Smoking Abstinence42 percentage of participants
eTARGET at 18 MonthsRate of Smoking Abstinence38 percentage of participants
eTARGET at 24 MonthsRate of Smoking Abstinence42 percentage of participants
Secondary

Changes in the Use of Tobacco Products

As a surveillance study, investigators will track changes in the use of both tobacco cigarettes and e-cigarettes over time for ASSESS group only

Time frame: 18 and 24 months post study enrollment

Population: For this outcome measure, only the ASSESS group was analyzed for naturalistic changes in smoking and e-cigarette use over time.

ArmMeasureValue (NUMBER)
ASSESS at 18 MonthsChanges in the Use of Tobacco Products33 percentage of participants
ASSESS at 24 MonthsChanges in the Use of Tobacco Products40 percentage of participants
GENERIC at 18 MonthsChanges in the Use of Tobacco Products27 percentage of participants
GENERIC at 24 MonthsChanges in the Use of Tobacco Products32 percentage of participants
Other Pre-specified

Study 2: Cost Effectiveness

Cost per incremental cessation will be measured using USD spent on the self help materials provided to the participants in the Generic and eTarget groups at 18 months and 24 months. \*\*\*Total cost was calculated for the intervention and not calculated as per participant cost

Time frame: 18 months and 24 months after study recruitment

Population: Participant groups evaluated at 18 and 24 months

ArmMeasureValue (NUMBER)
ASSESS at 18 MonthsStudy 2: Cost Effectiveness0 USD
ASSESS at 24 MonthsStudy 2: Cost Effectiveness0 USD
GENERIC at 18 MonthsStudy 2: Cost Effectiveness1535 USD
GENERIC at 24 MonthsStudy 2: Cost Effectiveness2369 USD
eTARGET at 18 MonthsStudy 2: Cost Effectiveness1000 USD
eTARGET at 24 MonthsStudy 2: Cost Effectiveness2253 USD

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026